Table 2. Lifestyle behaviours at baseline and follow-up and intervention effects from linear or logistic regression analyses.1 .
| Control group | Intervention group | |||
| Mean (SD);N | Mean (SD);N | β | 95% CI | |
| MVPA2 (min/wk) | ||||
| Baseline | 363.1 (3.5); N = 146 | 422.0 (3.1); N = 171 | ||
| 12 months | 428.0 (3.7); N = 146 | 501.0 (3.3); N = 171 | ||
| Difference | +64.9 | +79.0 | 1.113 | −0.12–0.33 |
| Saturated fat intake (fat points/day) | ||||
| Baseline | 14.3 (4.9) N = 146 | 15.4 (4.8) N = 171 | ||
| 12 months | 13.7 (4.6) N = 146 | 14.0 (5.0) N = 171 | ||
| Difference | −0.6 | −1.4 | −0.61 | −1.35–0.14 |
| Fruit intake (servings/day) | ||||
| Baseline | 1.4 (1.1); N = 145 | 1.5 (1.3); N = 169 | ||
| 12 months | 1.4 (1.1); N = 145 | 1.6 (1.1); N = 169 | ||
| Difference | +0.0 | +0.1 | 0.05 | −0.12–0.22 |
| Vegetables intake (grams/day) | ||||
| Baseline | 151.2 (77.8); N = 144 | 162.1 (75.8); N = 169 | ||
| 12 months | 163.4 (77.2); N = 146 | 171.5 (76.6); N = 169 | ||
| Difference | +12.2 | +9.4 | 3.26 | −9.78–16.29 |
| Smokers (%) | ||||
| Baseline | 15.2; N = 145 | 18.3; N = 171 | ||
| 12 months | 10.2; N = 146 | 13.5; N-171 | ||
| Difference | −5 | −4.8 | OR = 1.15 | 0.39–3.33 |
| Compliant to statin therapy (%)4 | ||||
| Baseline | 44.4; N = 99 | 38.1; N = 118 | ||
| 12 months | 51.4; N = 105 | 44.5; N = 119 | ||
| Difference | +7.0 | +6.4 | OR = 0.99 | 0.51–1.94 |
| Post-hoc analyses | ||||
| Saturated fat intake (fat points/day) in men | ||||
| Baseline | 16.3 (5.3); N = 63 | 16.7 (4.9); N = 73 | ||
| 12 months | 15.2 (4.5); N = 63 | 15.5 (5.2); N = 73 | ||
| Difference | −1.1 | −1.2 | −0.06 | −1.30–1.16 |
| Saturated fat intake (fat points/day) in women | ||||
| Baseline | 12.8 (3.9); N = 82 | 14.4 (4.5); N = 98 | ||
| 12 months | 12.6 (4.4); N = 83 | 12.8 (4.6); N = 98 | ||
| Difference | −0.2 | −1.6 | −1.03 | −1.98–−0.08 |
Differences between control and intervention group after 12 months are tested through linear of logistic regression analyses, controlled for baseline values and baseline BMI. N = sample size; SD = standard deviation; β/OR = beta or Odds ratio as effect indicators from linear or logistic regression analyses; 95% CI = 95% confidence interval as effect indicator from linear or logistic regression analyses; Significant differences between control and intervention group (P<0.05) printed in bold font.
MVPA = Physical activity with moderate to vigorous intensity; means are geometric means;
Log-linear regression was conducted;
Assessed with the MARS-5 questionnaire, a score = 25 is defined as compliant, < = 24 is defined as noncompliant.
Since no major differences were found between intention-to-treat analysis and complete case analysis, only the results of the complete case analysis are presented.